Impact of extending direct antiviral agents (DAA) availability in France: an observational cohort study (2015-2019) of data from French administrative healthcare databases (SNDS).

• Main Authors: Stanislas Pol (Author), Fayssoil Fouad (Author), Magali Lemaitre (Author), Ingrid Rodriguez (Author), Olivier Lada (Author), Pascaline Rabiega (Author), Elias Benabadji (Author), Françoise Roudot-Thoraval (Author)
• Format: Book
• Published: Elsevier, 2022-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: Direct antiviral agents (DAAs) became available in France in 2014 for the treatment of chronic hepatitis C (CHC) in patients with severe fibrosis (prioritized access); in 2017, DAAs became available to all CHC patients (universal access). We evaluated the impact of extending DAA...